Codexis, Inc. is an industrial biotechnology company that specializes in engineers enzymes for pharmaceutical and chemical production through biocatalysis. Codexis’ technologies enable scale-up and implementation of biocatalytic solutions to optimize process development, from research to manufacturing. There are currently over 50 pharmaceutical firms using Codexis’ technology, products and services in their manufacturing process development.
Codexis creates its products by applying its CodeEvolver® directed evolution technology platform, which introduces genetic mutations into microorganisms.
Codexis, Inc. began operations as an independent company in 2002, and became a publicly traded company in 2009. They are located in Redwood City, CA USA

Redwood City, US
Size (employees)
91 (est)-37%
Codexis was founded in 2002 and is headquartered in Redwood City, US

Key People at Codexis

John Nicols

John Nicols

President & CEO
James Lalonde

James Lalonde

Senior Vice President, Research & Development

Codexis Office Locations

Codexis has an office in Redwood City
Redwood City, US (HQ)
200 Penobscot Dr

Codexis Metrics

Codexis Financial Metrics

Codexis's revenue was reported to be $48.8 m in 2016

Revenue (Y, 2016)

$48.8 m

Revenue growth (Y, 2015 - Y, 2016), %


Gross profit (Y, 2016)

$39.1 m

Gross profit margin (Y, 2016), %


Net income (Y, 2016)

($8.6 m)

EBIT (Y, 2016)

($8.6 m)

Market capitalization (22-May-2017)

$221.6 m

Closing share price (22-May-2017)


Cash (31-Dec-2016)

$19.2 m
Codexis's current market capitalization is $221.6 m.
FY, 2013FY, 2014FY, 2015Y, 2016


$31.9 m$35.3 m$41.8 m$48.8 m

Revenue growth, %


Cost of goods sold

$9.8 m

Gross profit

$39.1 m

Gross profit Margin, %


Operating expense total

$73.1 m$54.4 m$49.6 m$57.4 m


($41.1 m)($19.1 m)($7.8 m)($8.6 m)

EBIT margin, %


Interest income

$60 k$18 k$19 k$60 k

Pre tax profit

($41.4 m)($19.3 m)($7.9 m)($8.6 m)

Income tax expense

($87 k)($256 k)

Net Income

($41.3 m)($19.1 m)($7.6 m)($8.6 m)
FY, 2013FY, 2014FY, 2015FY, 2016


$22.1 m$26.5 m$23.3 m$19.2 m

Accounts Receivable


$1.5 m$1.4 m$992 k$825 k

Current Assets

$35.8 m$33 m$32.8 m$27.2 m


$8.4 m$4 m$3.1 m$2.2 m


$3.2 m$3.2 m$3.2 m$3.2 m

Total Assets

$58.8 m$48.1 m$44.6 m$35.6 m

Accounts Payable

$4 m$4.7 m$3.4 m$4.2 m

Current Liabilities

$11.2 m$13.7 m$14.8 m$12.4 m

Additional Paid-in Capital

$298.4 m$302.4 m$306 m$311.2 m

Retained Earnings

($256.9 m)($275.9 m)($283.5 m)($292.1 m)

Total Equity

$22.9 m$19.1 m

Financial Leverage

2 x1.9 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($41.3 m)($19.1 m)($7.6 m)($8.6 m)

Accounts Receivable

$1.6 m$1.6 m($3.5 m)$1.4 m


($185 k)$92 k$403 k$167 k

Accounts Payable

$308 k$713 k($1.3 m)$942 k

Cash From Operating Activities

($23 m)$321 k($433 k)($2.7 m)

Purchases of PP&E

($1.2 m)($302 k)($1.2 m)($888 k)

Cash From Investing Activities

$13.3 m$4.6 m($1.3 m)($842 k)

Cash From Financing Activities

($147 k)($611 k)($1.5 m)($490 k)

Income Taxes Paid

$103 k$15 k$8 k$5 k
Y, 2016

Financial Leverage

1.9 x

Codexis Market Value History

Codexis Online Presence

Codexis Company Life

You may also be interested in